Hidradenitis suppurativa (HS) is a chronic systemic inflammatory disorder of the terminal follicular epithelium in the apocrine gland–bearing skin. Clinically, it is characterized by lesions, including comedones, papules, pustules, nodules, and fistulas, that are mainly concentrated in axillae, perineal, and submammary areas.1
Other autoimmune diseases are associated with ocular comorbidities; however, there is a paucity of data on ocular comorbidities in HS.1-4 In this article, we aim to quantify the burden of ocular comorbidities in patients with HS.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Conic RRZ, Fabbrocini G, Marasca C, et al. Burden of Ocular Comorbidities in Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2021;157(2):226–227. doi:10.1001/jamadermatol.2020.5087
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.